Tuve S - Search Results

1

In situ adenovirus vaccination engages T effector cells against cancer.

Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellström KE, Disis ML, Roffler S, Lieber A. Tuve S, et al. Vaccine. 2009 Jun 24;27(31):4225-39. doi: 10.1016/j.vaccine.2009.03.074. Epub 2009 Apr 16. Vaccine. 2009. PMID: 19481312 Free PMC article.

2

Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models.

Liu Y, Tuve S, Persson J, Beyer I, Yumul R, Li ZY, Tragoolpua K, Hellström KE, Roffler S, Lieber A. Liu Y, et al. Among authors: tuve s. Cancer Gene Ther. 2011 Jun;18(6):407-18. doi: 10.1038/cgt.2011.8. Epub 2011 Mar 11. Cancer Gene Ther. 2011. PMID: 21394107 Free PMC article.

3

Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.

DiPaolo N, Ni S, Gaggar A, Strauss R, Tuve S, Li ZY, Stone D, Shayakhmetov D, Kiviat N, Touré P, Sow S, Horvat B, Lieber A. DiPaolo N, et al. Among authors: tuve s. Mol Ther. 2006 Apr;13(4):756-65. doi: 10.1016/j.ymthe.2005.12.008. Epub 2006 Feb 7. Mol Ther. 2006. PMID: 16461009 Free PMC article.

4

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.

Di Paolo NC, Tuve S, Ni S, Hellström KE, Hellström I, Lieber A. Di Paolo NC, et al. Among authors: tuve s. Cancer Res. 2006 Jan 15;66(2):960-9. doi: 10.1158/0008-5472.CAN-05-2388. Cancer Res. 2006. PMID: 16424031 Free PMC article.

5

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

Tuve S, Wang H, Ware C, Liu Y, Gaggar A, Bernt K, Shayakhmetov D, Li Z, Strauss R, Stone D, Lieber A. Tuve S, et al. J Virol. 2006 Dec;80(24):12109-20. doi: 10.1128/JVI.01370-06. Epub 2006 Oct 4. J Virol. 2006. PMID: 17020944 Free PMC article.

6

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

Tuve S, Chen BM, Liu Y, Cheng TL, Touré P, Sow PS, Feng Q, Kiviat N, Strauss R, Ni S, Li ZY, Roffler SR, Lieber A. Tuve S, et al. Cancer Res. 2007 Jun 15;67(12):5929-39. doi: 10.1158/0008-5472.CAN-06-4296. Cancer Res. 2007. PMID: 17575163

7

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.

Stone D, Liu Y, Li ZY, Tuve S, Strauss R, Lieber A. Stone D, et al. Among authors: tuve s. Mol Ther. 2007 Dec;15(12):2146-53. doi: 10.1038/sj.mt.6300319. Epub 2007 Sep 25. Mol Ther. 2007. PMID: 17895860 Free article.

8

In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.

Wang H, Liu Y, Li Z, Tuve S, Stone D, Kalyushniy O, Shayakhmetov D, Verlinde CL, Stehle T, McVey J, Baker A, Peng KW, Roffler S, Lieber A. Wang H, et al. Among authors: tuve s. J Virol. 2008 Nov;82(21):10567-79. doi: 10.1128/JVI.01308-08. Epub 2008 Aug 27. J Virol. 2008. PMID: 18753195 Free PMC article.

9

Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.

Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, Lieber A. Tuve S, et al. PLoS Pathog. 2008 Oct;4(10):e1000189. doi: 10.1371/journal.ppat.1000189. Epub 2008 Oct 31. PLoS Pathog. 2008. PMID: 18974862 Free PMC article.

10

Toward a stem cell gene therapy for breast cancer.

Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A. Li Z, et al. Among authors: tuve s. Blood. 2009 May 28;113(22):5423-33. doi: 10.1182/blood-2008-10-187237. Epub 2009 Mar 27. Blood. 2009. PMID: 19329780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters